The second strategy focuses on DPP-4 inhibitors, which prevent the rapid degradation of endogenous GLP-1 by inhibiting the DPP-4 enzyme, thereby extending the hormone's activity
Slowing kidney decline in the SURPASS-CVOT trial In patients with high or very high risk chronic kidney disease enrolled in SURPASS-CVOT, tirzepatide dramatically slowed the rate of kidney function decline compared to dulaglutide
How can I monitor my Vitamin B12 levels while using GLP-1 medications, and what steps should I take if theyre low
Beyond that, the evidence is per-compound plus the CagriSema (cag + sema) Phase 3 data as the closest human analog
It's highly dependent on a constellation of factors, from the specific molecule being used to the protocol it's being used in
Metabolic Brain Disease 30, 519527.CrossRefGoogle ScholarPubMed Sheikh, HI, Dougherty, LR, Hayden, EP, Klein, DN and Singh, SM (2010) Glucagon-like peptide-1 receptor gene polymorphism (Leu260Phe) is associated with morning cortisol in preschoolers